FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2004143324> ?p ?o ?g. }

• W2004143324 endingPage "282" @default.
• W2004143324 startingPage "273" @default.
• W2004143324 abstract "Perflubron is a perfluorocarbon with unique physical characteristics. It has twice the density of water, allows free diffusion of O2 and CO2, is easily dispersed, and is insoluble. Thus, it can act as liquid positive end-expiratory pressure to recruit collapsed alveoli and improve oxygenation. Results of laboratory studies suggest that perflubron exerts an anti-inflammatory effect on alveolar cells. Limited clinical data in neonates and adults with severe acute respiratory distress syndrome are promising. We present a single institution's experience with partial liquid ventilation (PLV) in trauma patients compared with conventional mechanical ventilation (CMV) with particular attention to the alveolar inflammatory response.Ventilated patients with bilateral lung injury and PaO2/FIO2 < 300 were eligible in this prospective multicenter trial. Perflubron was administered by means of the endotracheal tube to fill up to functional residual capacity (approximately 30 mL/kg), followed by supplemental doses up to 96 hours. At this institution, bronchoscopy with bronchoalveolar lavage was performed serially for white blood cell count, protein, interleukin (IL)-1, IL-6, IL-8, and IL-10, and analyzed as early (< 48 hours) and late (48-96 hours). Clinical response was defined as a sustained 10% increase in PaO2/FIO2 at 48 hours.16 patients were enrolled: 12 PLV patients and 4 CMV patients. There were no differences between groups relative to sex, Injury Severity Score, or initial PaO2/FIO2. There were no major outcome differences between groups in this pilot study relative to pneumonia (50% PLV and 75% CMV), deaths (one death in each group caused by multiple organ failure), or for oxygenation after 5 days. Eight PLV patients were responders (PLV-R) compared with four patients who did not (PLV-NR). The main differences between these subgroups was time from injury to study (1.8 days for PLV-R vs. 5.8 for PLV-NR, p < 0.02) and age (30 years for PLV-R vs. 42 years for PLV-NR, p < 0.04). Both white blood cell count and protein were higher in CMV, suggesting a greater inflammatory response. Neutrophils were significantly higher in CMV, despite equal IL-8 levels in both PLV and CMV. The inflammatory cytokines IL-1 and IL-6 were greater in CMV, and the anti-inflammatory IL-10 was lower in PLV.Early institution of partial liquid ventilation is effective at reducing the alveolar inflammatory response. Perflubron exhibits an anti-inflammatory effect in the alveolar environment with reduction of proinflammatory IL-1 and IL-6 (possibly removing a stimulus for IL-10), white blood cell count, and protein capillary leak. PLV also reduces alveolar neutrophils independent of IL-8. Further characterization of this altered inflammatory response is necessary." @default.
• W2004143324 created "2016-06-24" @default.
• W2004143324 creator A5014291446 @default.
• W2004143324 creator A5020143454 @default.
• W2004143324 creator A5023545580 @default.
• W2004143324 creator A5040586649 @default.
• W2004143324 creator A5076223278 @default.
• W2004143324 creator A5089053265 @default.
• W2004143324 date "1998-08-01" @default.
• W2004143324 modified "2023-10-15" @default.
• W2004143324 title "Partial Liquid Ventilation Decreases the Inflammatory Response in the Alveolar Environment of Trauma Patients" @default.
• W2004143324 cites W1976735411 @default.
• W2004143324 cites W1993987479 @default.
• W2004143324 cites W1995488303 @default.
• W2004143324 cites W2003442522 @default.
• W2004143324 cites W2005357317 @default.
• W2004143324 cites W2006356492 @default.
• W2004143324 cites W2008305761 @default.
• W2004143324 cites W2015847308 @default.
• W2004143324 cites W2024279491 @default.
• W2004143324 cites W2027107170 @default.
• W2004143324 cites W2028072481 @default.
• W2004143324 cites W2030208822 @default.
• W2004143324 cites W2058494256 @default.
• W2004143324 cites W2063803981 @default.
• W2004143324 cites W2064605932 @default.
• W2004143324 cites W2067594941 @default.
• W2004143324 cites W2067804184 @default.
• W2004143324 cites W2075725232 @default.
• W2004143324 cites W2091210055 @default.
• W2004143324 cites W2149954848 @default.
• W2004143324 cites W2151673496 @default.
• W2004143324 cites W2152909001 @default.
• W2004143324 cites W2159075850 @default.
• W2004143324 cites W2332939473 @default.
• W2004143324 cites W4232548876 @default.
• W2004143324 doi "https://doi.org/10.1097/00005373-199808000-00012" @default.
• W2004143324 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9715184" @default.
• W2004143324 hasPublicationYear "1998" @default.
• W2004143324 type Work @default.
• W2004143324 sameAs 2004143324 @default.
• W2004143324 citedByCount "97" @default.
• W2004143324 countsByYear W20041433242012 @default.
• W2004143324 countsByYear W20041433242013 @default.
• W2004143324 countsByYear W20041433242014 @default.
• W2004143324 countsByYear W20041433242015 @default.
• W2004143324 countsByYear W20041433242016 @default.
• W2004143324 countsByYear W20041433242020 @default.
• W2004143324 countsByYear W20041433242021 @default.
• W2004143324 countsByYear W20041433242022 @default.
• W2004143324 crossrefType "journal-article" @default.
• W2004143324 hasAuthorship W2004143324A5014291446 @default.
• W2004143324 hasAuthorship W2004143324A5020143454 @default.
• W2004143324 hasAuthorship W2004143324A5023545580 @default.
• W2004143324 hasAuthorship W2004143324A5040586649 @default.
• W2004143324 hasAuthorship W2004143324A5076223278 @default.
• W2004143324 hasAuthorship W2004143324A5089053265 @default.
• W2004143324 hasConcept C126322002 @default.
• W2004143324 hasConcept C2776348555 @default.
• W2004143324 hasConcept C2777080012 @default.
• W2004143324 hasConcept C2777184939 @default.
• W2004143324 hasConcept C2777714996 @default.
• W2004143324 hasConcept C2777914695 @default.
• W2004143324 hasConcept C2777961210 @default.
• W2004143324 hasConcept C2778917391 @default.
• W2004143324 hasConcept C42219234 @default.
• W2004143324 hasConcept C70289976 @default.
• W2004143324 hasConcept C71924100 @default.
• W2004143324 hasConceptScore W2004143324C126322002 @default.
• W2004143324 hasConceptScore W2004143324C2776348555 @default.
• W2004143324 hasConceptScore W2004143324C2777080012 @default.
• W2004143324 hasConceptScore W2004143324C2777184939 @default.
• W2004143324 hasConceptScore W2004143324C2777714996 @default.
• W2004143324 hasConceptScore W2004143324C2777914695 @default.
• W2004143324 hasConceptScore W2004143324C2777961210 @default.
• W2004143324 hasConceptScore W2004143324C2778917391 @default.
• W2004143324 hasConceptScore W2004143324C42219234 @default.
• W2004143324 hasConceptScore W2004143324C70289976 @default.
• W2004143324 hasConceptScore W2004143324C71924100 @default.
• W2004143324 hasIssue "2" @default.
• W2004143324 hasLocation W20041433241 @default.
• W2004143324 hasLocation W20041433242 @default.
• W2004143324 hasOpenAccess W2004143324 @default.
• W2004143324 hasPrimaryLocation W20041433241 @default.
• W2004143324 hasRelatedWork W1981731833 @default.
• W2004143324 hasRelatedWork W2016869710 @default.
• W2004143324 hasRelatedWork W2047537223 @default.
• W2004143324 hasRelatedWork W2095067395 @default.
• W2004143324 hasRelatedWork W2368865276 @default.
• W2004143324 hasRelatedWork W2406153264 @default.
• W2004143324 hasRelatedWork W2460846704 @default.
• W2004143324 hasRelatedWork W2793502035 @default.
• W2004143324 hasRelatedWork W3032528766 @default.
• W2004143324 hasRelatedWork W3217749975 @default.
• W2004143324 hasVolume "45" @default.
• W2004143324 isParatext "false" @default.
• W2004143324 isRetracted "false" @default.
• W2004143324 magId "2004143324" @default.

• next